London-based payments platform Zilch has raised more than €150 million ($175 million) in a new mix of debt and equity funding, positioning the company to scale aggressively across the UK and EMEA.
London-based payments platform Zilch has raised more than €150 million ($175 million) in a new mix of debt and equity funding, positioning the company to scale aggressively across the UK and EMEA.
T-Therapeutics, a UK biotech developing next-generation T cell receptor (TCR) therapies for cancer and autoimmune diseases, has expanded its Series A round with an additional €27.5 million ($32 million) in funding.
Adclear, the AI compliance platform for financial marketing teams, has raised an oversubscribed £2.1 million (€2.4M) seed round led by Outward VC, with participation from AFG Partners, Tenity, angel investors including Clearscore founder Dan Cobley and Coinbase MD Keith Grose (via the a16z Scout Fund), plus community investors from Ventures
Biotech startup Scripta Therapeutics has emerged from stealth with a €10.3 million ($12 million USD) seed round to transform how new medicines are discovered.
Digital safety startup FALKIN has raised $2 million in pre-seed funding to expand its mission of stopping scams before payments occur — addressing one of the fastest-growing risks in the AI era.
London-based Inforcer, a platform helping Managed Service Providers (MSPs) manage and secure Microsoft environments, has raised $35 million in Series B funding led by Dawn Capital, with participation from existing investor Meritech Capital.
Biomaterials innovator PACT has raised €17.2 million ($20 million) in Series A funding to accelerate the commercial launch of Oval, its collagen-based, sustainable alternative to plastic-coated textiles.
Data lineage pioneer Solidatus has secured £5 million in funding from the Growth Debt Fund at Salica Investments to expand its AI capabilities and accelerate product innovation.
Premium dog food brand Marleybones has raised £2.5 million in new funding to expand its popular Pantry Fresh® range and accelerate growth across the UK pet nutrition market.
Advanced materials innovator Immaterial has raised €15.4 million in Series A2 funding to accelerate the commercial rollout of its monolithic metal–organic frameworks (m-MOFs) — a breakthrough material platform designed to cut costs and boost efficiency across industrial decarbonisation, carbon capture, and hydrogen storage.
